XNAS
PRVA
Market cap2.38bUSD
Aug 07, Last price
19.51USD
1D
-1.37%
1Q
-22.02%
IPO
-46.28%
Name
Privia Health Group Inc
Chart & Performance
P/E
165.36
P/S
1.37
EPS
0.12
Div Yield, %
—
Shrs. gr., 5y
3.51%
Rev. gr., 5y
17.17%
Revenues
1.74b
+4.74%
Net income
14m
-37.67%
CFO
109m
+35.28%
Profile
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 1,736,390 4.74% | 1,657,737 22.19% | 1,356,660 40.41% | ||||
Cost of revenue | 1,712,140 | 1,630,555 | 1,371,211 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 24,250 | 27,182 | (14,551) | ||||
NOPBT Margin | 1.40% | 1.64% | |||||
Operating Taxes | 10,826 | 7,993 | (6,516) | ||||
Tax Rate | 44.64% | 29.41% | |||||
NOPAT | 13,424 | 19,189 | (8,035) | ||||
Net income | 14,385 -37.67% | 23,079 -291.30% | (12,064) -93.67% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 8,740 | 13,448 | |||||
BB yield | -0.30% | -0.53% | |||||
| Debt | |||||||
Debt current | 2,553 | 6,086 | 3,013 | ||||
Long-term debt | 8,627 | 13,535 | 19,993 | ||||
Deferred revenue | (11,497) | ||||||
Other long-term liabilities | 153 | 313 | 1,000 | ||||
Net debt | (479,969) | (369,890) | (324,986) | ||||
| Cash flow | |||||||
Cash from operating activities | 109,282 | 80,785 | 47,196 | ||||
CAPEX | (113) | (104) | |||||
Cash from investing activities | (11,978) | (42,971) | (104) | ||||
Cash from financing activities | 4,334 | 3,705 | (19,677) | ||||
FCF | 16,291 | 21,727 | (5,374) | ||||
| Balance | |||||||
Cash | 491,149 | 389,511 | 347,992 | ||||
Long term investments | |||||||
Excess cash | 404,330 | 306,624 | 280,159 | ||||
Stockholders' equity | (129,762) | (146,480) | (195,590) | ||||
Invested Capital | 818,952 | 765,514 | 715,645 | ||||
ROIC | 1.69% | 2.59% | |||||
ROCE | 3.52% | 4.39% | |||||
| EV | |||||||
Common stock shares outstanding | 125,614 | 124,686 | 110,695 | ||||
Price | 19.55 -15.11% | 23.03 1.41% | 22.71 -12.21% | ||||
Market cap | 2,455,757 -14.48% | 2,871,520 14.23% | 2,513,889 -9.89% | ||||
EV | 2,024,052 | 2,547,582 | 2,208,858 | ||||
EBITDA | 31,518 | 33,715 | (9,980) | ||||
EV/EBITDA | 64.22 | 75.56 | |||||
Interest | 542 | ||||||
Interest/NOPBT | |||||||